Dr. Pallavi Sunkavalli, MD

Dr. Sunkavalli practices at Coosa Valley Medical Center in Sylacauga, Alabama, part of City of Sylacauga.

Dr. Sunkavalli's NPI, 1184878639, was assigned on November 11, 2008. Dr. Sunkavalli holds Alabama license 29697.

Dr. Sunkavalli's primary practice is Coosa Valley Medical Center, at 315 W Hickory St, Sylacauga, AL 35150 in Talladega County. The practice phone is (256) 249-5000.

Dr. Sunkavalli's primary practice is Coosa Valley Medical Center in Sylacauga, Alabama, part of City of Sylacauga. Dr. Sunkavalli is also affiliated with Baptist Medical Center East. The medical group on file is NES Health. Dmand AI also links Dr. Sunkavalli to 5 more hospitals, 7 medical groups, 2 group practices and clinics, 1 behavioral health center and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sunkavalli practices, 11 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sunkavalli's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sunkavalli is licensed in Alabama.

CMS data shows 631 Medicare services from Dr. Sunkavalli across 7 procedure codes in 2024, for 371 Medicare patients. Medicare paid $50,494 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 371 Medicare patients who saw Dr. Sunkavalli in 2024. The largest group is 75 to 84, with 132 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sunkavalli's median patient age at 70, with 59% women.

In 2024, Dr. Sunkavalli wrote 449 Medicare Part D claims for 330 patients. 95% of them were for generic drugs. CMS names the drug for 301 of them, across 12 drugs with 11 or more claims each, at $2,090 in total drug cost. In 2023, CMS named 177 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Sunkavalli for performance year 2024, reported as part of a group. Dr. Sunkavalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Dr. Sunkavalli from 3 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $49.